Document ID: chunk:federal_register_of_legislation:F2021N00183:front:0
Version: federal_register_of_legislation:F2021N00183
Segment Type: other
Provision Reference: 
Character Range: 0–2160

National Health (August 2021 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2021
National Health Act 1953

I, Nikolai Tsyganov, Acting Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health and Aged Care make this determination under subsections 99ACB(6A) and 99ACF(3AA) of the National Health Act 1953.

Dated        30 July 2021

NIKOLAI TSYGANOV
Acting Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health

1 Name of Determination
  This instrument is the National Health (August 2021 First New Brand statutory price reduction) (Exercise of Ministerial discretion) Determination 2021.

2 Commencement
  This instrument commences on 1 August 2021.
3 Definition

          Note: A number of expressions used in this instrument are defined in Part VII the Act,

      In this instrument:

       Act means the National Health Act 1953.
4 Authority

      This instrument is made under subsection 99ACB(6A) and subsection 99ACF(3AA) of the Act.
5 Brands of pharmaceutical items with approved ex-manufacturer price not reduced

  (1) I determine under subsection 99ACB(6A) of the Act that, for the purposes of subsection 99ACB(5), the approved ex-manufacturer price that comes into force on 1 August 2021 of the brand of pharmaceutical item specified in column 2 of item 1 in the table in Schedule 1 is to be worked out using a reduction of zero %.

      (2) I determine under subsection 99ACF(3AA) of the Act that, for the purposes of subsection 99ACF(2AB), the approved ex-manufacturer price that comes into force on 1 August 2021 of the brand of pharmaceutical item specified in column 2 of  item 2 in the table in Schedule 1 is to be worked out using a reduction of zero %.

Schedule 1— Brands of pharmaceutical items with approved ex-manufacturer price not reduced

Column 1  Column 2
Item      Brand of Pharmaceutical Item
          Drug                          Form                             Manner of administration  Brand